H-RYK, an unusual receptor kinase: Isolation and analysis of expression in ovarian cancer

Molecular Medicine

Volumn 2, Issue 2, 1996, Pages 189-203

  Wang, Xiao C ^a   Katso, Roy ^a   Butler, Robin ^a   Hanby, Andrew M ^b   Poulsom, Richard ^b   Jones, Tania ^c   Sheer, Denise ^c   Ganesan, Trivadi S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c Laboratory of Human Cytogenetics   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN TYROSINE KINASE;

ARTICLE; DNA LIBRARY; EPITHELIUM CELL; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION;

EID: 0029752981     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401616     Document Type: Article

References (40)

1. Hunter T. (1987) A thousand and one protein kinases. Cell 50: 823-829.
2. Hanks SK, Quinn AM, Hunter T. (1988) The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52.
3. Schlessinger J, Ullrich A. (1992) Growth factor signalling by receptor tyrosine kinases. Neuron 9: 383-391.
4. Pawson T. (1995) Protein modules and signalling networks. Nature 373: 573-579.
5. Pawson T. (1995) Getting down to specifics. Nature 373: 477-478.
6. Darnell Jr JE, Kerr IM, Stark GR. (1994) Jak-STAT pathways and transcriptional activation in response to IFNS and other extracellular signalling proteins. Science 264: 1415-1421.
7. Heldin C-H. (1995) Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223.
8. Cantley LC, Auger KR, Carpenter C, et al. (1991) Oncogenes and signal transduction. Cell 64: 281-302.
9. Slamon DJ, Godolphin W, Jones LA, et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712.
10. Baserga R. (1995) The insulin-like growth factor I receptor: A key to tumor growth? Cancer Res. 55: 249-252.
11. Eng C, Smith DP, Mulligan LM, et al. (1994) Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet. 3: 237-241.
12. Mulligan LM, Kwok JBJ, Healey CS, et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460.
13. Songyang Z, Carraway KL, Eck MJ, et al. (1995) Catalytic specificity of protein tyrosine kinases is critical for selective signalling. Nature 373: 536-539.
14. Shaing R, Thompson LM, Zhu Y-Z. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78: 335-342.
15. Wilks AF. (1989) Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A. 86: 1603-1607.
16. Laval S, Butler R, Shelling AN, Hanby AM, Poulsom R, Ganesan TS. (1994) Isolation and characterisation of an epithelial specific-receptor kinase from an ovarian cancer cell line. Cell Growth Differ. 5: 1173-1183.
17. Stacker SA, Hovens CM, Vitali A, et al. (1993) Molecular cloning and chromosomal localisation of the human homologue of a receptor related to tyrosine kinases. Oncogene 8: 1347-1356.
18. Tamagnone L, Partanen J, Armstrong E, et al. (1993) The human RYK cDNA sequence-predicts a protein containing two putative transmembrane segments and a tyrosine kinase catalytic domain. Oncogene 8: 2009-2014.
19. Sanger F, Nicklen S, Coulson R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74: 5463-5467.
20. Senior PV, Critchley DR, Beck F, Walker RA, Varley JM. (1988) The localisation of laminin mRNA and protein in the postimplantation embryo and placenta of mouse: An in situ and immunocytochemical study. Development 104: 431-446.
21. Walker LC, Ganesan TS, Dhut S, et al. (1987) Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. Nature 329: 851-853.
22. Laemmli UK. (1970) Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227: 680-685.
23. Rooney DE, Czepulkowski BH (eds). (1986) Human Genetics: A Practical Approach. IRL Press, London.
24. Shelling AN, Butler R, Jones T, Laval S, Boyle JM, Ganesan TS. (1995) Localisation of an epithelial-specific receptor kinase (EDDR1) to chromosome 6q16. Genomics 25: 584-587.
25. Ullrich A, Bell JR, Chen EY, et al. (1985) Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313: 756-761.
26. Smith D, Vogt PK, Hayman MJ. (1989) The v-sea oncogene of avian erythroblastosis virus S13 - Another member of the protein tyrosine kinase gene family. Proc. Natl. Acad. Sci. U.S.A. 86: 5291-5295.
27. Songyang Z, Shoelson SE, Chaudhuri M, et al. (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778.
28. Songyang Z, Shoelson SE, McGlade J, et al. (1994) Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14: 2777-2785.
29. Hubbard SR, Wei L, Ellis L, Hendrickson WA. (1994) Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372: 746-753.
30. Moran MF, Kock CA, Sadowski I, Pawson T. (1988) Mutational analysis of a phosphotransfer motif essential for v-fps tyrosine kinase activity. Oncogene 3: 665-672.
31. Chou Y-H, Hayman MJ. (1991) Characterisation of a member of the immunoglobulin gene superfamily that possibly represents an additional class of growth factor receptor. Proc. Natl. Acad. Sci. U.S.A. 88: 4897-4901.
32. White MF. (1994) The IRS-1 signaling system. Curr. Opin. Genet. Dev. 4: 47-54.
33. Hovens CM, Stacker SA, Andres A-C, Harpur AG, Ziemiecki A, Wilks AF. (1992) RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifs. Proc. Natl. Acad. Sci. U.S.A. 89: 11818-11822.
34. Kelman Z, Simon-Chazottes D, Guenet J-L, Yarden Y. (1993) The murine vik gene (chromosome 9) encodes a putative receptor with unique protein kinase motifs. Oncogene 8: 37-44.
35. Bansal A, Gierasch LM. (1991) The NPXY internalization signal of the LDL receptor adopts a reverse-turn conformation. Cell 67: 1195-1201.
36. Chen W-J, Goldstein J, Brown MS. (1990) NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J. Biol. Chem. 265: 3116-3123.
37. Kavanaugh WM, Turck CW, Williams LT. (1995) PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science 268: 1177-1179.
38. Prigent SA, Gullick WJ. (1994) Identification of c-erbB-3 binding sites for phosphatidyl-inositol 3′kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J. 13: 2831-2841.
39. Wallasch C, Weib FU, Niederfellner F, Jallal B, Issing W, Ullrich A. (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J. 14: 4267-4275.
40. Callahan CA, Muralidhar MG, Lundgren SE, Scully AL, Thomas JB. (1995) Control of neuronal pathway selection by a Drosophila receptor protein-tyrosine kinase family member. Nature 376: 171-174.